Physician profile
Patrick H Eakes
NPI 1194739656
$1,085.47
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $468 · 2021: $343 · 2022: $136.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $261.49 | 2019-2021 | |
| Lilly USA, LLC | $190.70 | 2020-2022 | |
| Novo Nordisk INC | $148.03 | 2019-2022 | |
| Glaxosmithkline, LLC. | $123.28 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $104.03 | 2019-2021 | |
| Amgen INC. | $48.17 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.24 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.64 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $27.57 | 2019 | |
| Allergan, INC. | $26.36 | 2020 | |
| Abbott Laboratories | $22.45 | 2021 | |
| Abbvie INC. | $19.70 | 2021 | |
| Sanofi Pasteur INC. | $14.95 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $10.86 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Eakes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.